15019AST
Astec® CHIROBIOTIC® V2 Chiral (5 μm) HPLC Columns
L × I.D. 15 cm × 2.1 mm, HPLC Column
Synonym(s):
Chiral Stationary Phase Column V2
About This Item
Recommended Products
product name
Astec® CHIROBIOTIC® V2 Chiral HPLC Column, 5 μm particle size, L × I.D. 15 cm × 2.1 mm
material
stainless steel column
Agency
suitable for USP L88
description
HPLC column
product line
Astec®
packaging
pkg of 1 ea
manufacturer/tradename
Astec®
parameter
0-45 °C temperature
241 bar pressure (3500 psi)
technique(s)
HPLC: suitable
LC/MS: suitable
L × I.D.
15 cm × 2.1 mm
matrix
High-purity silica gel particle platform
fully porous particle
matrix active group
vancomycin phase
particle size
5 μm
pore size
200 Å
operating pH range
3.5-7.0
separation technique
chiral
Looking for similar products? Visit Product Comparison Guide
Related Categories
General description
- Bonded phase: Vancomycin
- Operating pH range: 3.5 - 7.0
- Particle diameter: 5, 10 or 16 μm
- Pore size: 100 Å (CHIROBIOTIC® V) or 200 Å (CHIROBIOTIC® V2)
CHIROBIOTIC FAQs
CHIROBIOTIC Reference Bibliography
Chiral Product Literature
Application
- Development and validation of an UFLC-MS/MS method for enantioselectivity determination of d,l-thero-methylphenidate, d,l-thero-ethylphenidate and d,l-thero-ritalinic acid in rat plasma and its application to pharmacokinetic study.: This study highlights the application of the Astec® CHIROBIOTIC® V2 chiral HPLC column in the pharmacokinetic assessment of chiral drugs, demonstrating its utility in accurate and efficient chiral separation for analytical chemistry in pharmacological research (Zhang et al., 2016).
- New high-performance liquid chromatography method for the determination of (R)-warfarin and (S)-warfarin using chiral separation on a glycopeptide-based stationary phase.: This paper describes a method using the Astec® CHIROBIOTIC® V2 chiral HPLC column to differentiate between the enantiomers of warfarin, showcasing its critical role in therapeutic drug monitoring and clinical pharmacology, which is essential for ensuring patient safety and efficacy in treatments (Malakova et al., 2009).
Legal Information
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service